Based in Mumbai, Indoco Remedies was formed in Aug. 23, 1947. Indoco Remedies (INDOCO) makes formulations. The company also has a presence in contract manufacturing and research. It also trades some active pharma ingredients (APIs) manufactured by a group company. It has presence in the therapeutic segments including anti-infective, anti-cold preparation, opthalmic, anti-spasmodic, stomatology, anti-inflammatory and anti-fungal. The company`s shareholders are SPA Pharmaceuticals and Shanteri Investments. The company recently launched a new super specialty division with focus on diabetic and cardio-vascular segments. It has formed a 100% subsidiary, Indoco Holdings Netherlands BV, which would invest in Indoco UK and Indoco SA Pty a JV in South Africa. Indoco`s other subsidiary is Indoco Healthcare. In 2004-05, Indoco launched Methycal, a unique calcium supplement. It also acquired a brand Karvol Plus in the segment of decongestive inhalant from M/s Solvay Pharma (I) . Indoco availed of ECB loan of USD 2.50 million for financing the expansion of tablet facility of plant I at Verna. INDOCO exports branded formulations to several Asian and African countries